vs
Ceribell, Inc.（CBLL）与Electromed, Inc.（ELMD）财务数据对比。点击上方公司名可切换其他公司
Ceribell, Inc.的季度营收约是Electromed, Inc.的1.3倍（$24.8M vs $18.9M）。Electromed, Inc.净利率更高（14.6% vs -54.6%，领先69.2%）。Electromed, Inc.自由现金流更多（$2.4M vs $-11.0M）
Ceribell, Inc.是一家专注于神经诊断领域的医疗科技企业，主打便携式快速脑电图检测设备，可为急症、重症护理场景提供便捷的癫痫发作监测解决方案，核心市场覆盖北美地区，目前正逐步推进全球化业务布局。
Electromed, Inc.是一家专注于呼吸护理设备研发、生产与销售的医疗设备企业，核心产品为高频胸壁振荡排痰系统，主要服务美国市场的家庭护理及临床医疗机构，为囊性纤维化、慢阻肺等呼吸系统疾病患者提供气道清理解决方案。
CBLL vs ELMD — 直观对比
营收规模更大
CBLL
是对方的1.3倍
$18.9M
净利率更高
ELMD
高出69.2%
-54.6%
自由现金流更多
ELMD
多$13.3M
$-11.0M
损益表 — Q4 2025 vs Q2 2026
| 指标 | | |
|---|---|---|
| 营收 | $24.8M | $18.9M |
| 净利润 | $-13.5M | $2.8M |
| 毛利率 | 87.3% | 78.4% |
| 营业利润率 | -58.9% | 19.2% |
| 净利率 | -54.6% | 14.6% |
| 营收同比 | — | 16.3% |
| 净利润同比 | — | 40.3% |
| 每股收益（稀释后） | $-0.35 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CBLLELMD
| Q4 25 | $24.8M | $18.9M | ||
| Q3 25 | $22.6M | $16.9M | ||
| Q2 25 | $21.2M | $17.4M | ||
| Q1 25 | $20.5M | $15.7M | ||
| Q4 24 | — | $16.3M | ||
| Q3 24 | $17.2M | $14.7M | ||
| Q2 24 | — | $14.8M | ||
| Q1 24 | — | $13.9M |
净利润CBLLELMD
| Q4 25 | $-13.5M | $2.8M | ||
| Q3 25 | $-13.5M | $2.1M | ||
| Q2 25 | $-13.6M | $2.2M | ||
| Q1 25 | $-12.8M | $1.9M | ||
| Q4 24 | — | $2.0M | ||
| Q3 24 | $-10.4M | $1.5M | ||
| Q2 24 | — | $1.8M | ||
| Q1 24 | — | $1.5M |
毛利率CBLLELMD
| Q4 25 | 87.3% | 78.4% | ||
| Q3 25 | 88.3% | 78.1% | ||
| Q2 25 | 88.1% | 78.3% | ||
| Q1 25 | 87.9% | 78.0% | ||
| Q4 24 | — | 77.7% | ||
| Q3 24 | 87.3% | 78.3% | ||
| Q2 24 | — | 76.2% | ||
| Q1 24 | — | 74.8% |
营业利润率CBLLELMD
| Q4 25 | -58.9% | 19.2% | ||
| Q3 25 | -64.8% | 15.8% | ||
| Q2 25 | -70.5% | 17.5% | ||
| Q1 25 | -69.3% | 13.6% | ||
| Q4 24 | — | 15.6% | ||
| Q3 24 | -57.8% | 13.2% | ||
| Q2 24 | — | 15.7% | ||
| Q1 24 | — | 13.3% |
净利率CBLLELMD
| Q4 25 | -54.6% | 14.6% | ||
| Q3 25 | -59.6% | 12.6% | ||
| Q2 25 | -64.4% | 12.7% | ||
| Q1 25 | -62.4% | 12.1% | ||
| Q4 24 | — | 12.1% | ||
| Q3 24 | -60.6% | 10.0% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 10.8% |
每股收益（稀释后）CBLLELMD
| Q4 25 | $-0.35 | $0.32 | ||
| Q3 25 | $-0.37 | $0.25 | ||
| Q2 25 | $-0.38 | $0.26 | ||
| Q1 25 | $-0.36 | $0.21 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | $-1.85 | $0.16 | ||
| Q2 24 | — | $0.20 | ||
| Q1 24 | — | $0.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $159.3M | $13.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $155.3M | $45.4M |
| 总资产 | $195.8M | $54.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CBLLELMD
| Q4 25 | $159.3M | $13.8M | ||
| Q3 25 | $168.5M | $14.1M | ||
| Q2 25 | $177.4M | $15.3M | ||
| Q1 25 | $182.7M | $15.2M | ||
| Q4 24 | — | $16.2M | ||
| Q3 24 | $14.1M | $13.9M | ||
| Q2 24 | — | $16.1M | ||
| Q1 24 | — | $11.7M |
股东权益CBLLELMD
| Q4 25 | $155.3M | $45.4M | ||
| Q3 25 | $164.1M | $44.7M | ||
| Q2 25 | $172.2M | $43.2M | ||
| Q1 25 | $180.9M | $43.9M | ||
| Q4 24 | — | $43.6M | ||
| Q3 24 | $-136.0M | $41.5M | ||
| Q2 24 | — | $44.5M | ||
| Q1 24 | — | $42.5M |
总资产CBLLELMD
| Q4 25 | $195.8M | $54.9M | ||
| Q3 25 | $199.5M | $53.6M | ||
| Q2 25 | $207.7M | $53.8M | ||
| Q1 25 | $213.5M | $52.5M | ||
| Q4 24 | — | $52.3M | ||
| Q3 24 | $47.1M | $48.9M | ||
| Q2 24 | — | $52.2M | ||
| Q1 24 | — | $48.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.8M | $3.0M |
| 自由现金流经营现金流 - 资本支出 | $-11.0M | $2.4M |
| 自由现金流率自由现金流/营收 | -44.2% | 12.7% |
| 资本支出强度资本支出/营收 | 0.7% | 3.4% |
| 现金转化率经营现金流/净利润 | — | 1.10× |
| 过去12个月自由现金流最近4个季度 | $-41.6M | $7.9M |
8季度趋势，按日历期对齐
经营现金流CBLLELMD
| Q4 25 | $-10.8M | $3.0M | ||
| Q3 25 | $-11.1M | $169.0K | ||
| Q2 25 | $-7.5M | $3.9M | ||
| Q1 25 | $-11.4M | $2.1M | ||
| Q4 24 | — | $3.2M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $4.5M | ||
| Q1 24 | — | $1.4M |
自由现金流CBLLELMD
| Q4 25 | $-11.0M | $2.4M | ||
| Q3 25 | $-11.5M | $-83.0K | ||
| Q2 25 | $-7.6M | $3.7M | ||
| Q1 25 | $-11.6M | $1.9M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $4.5M | ||
| Q1 24 | — | $1.3M |
自由现金流率CBLLELMD
| Q4 25 | -44.2% | 12.7% | ||
| Q3 25 | -50.8% | -0.5% | ||
| Q2 25 | -35.9% | 21.4% | ||
| Q1 25 | -56.4% | 12.2% | ||
| Q4 24 | — | 18.0% | ||
| Q3 24 | — | 15.5% | ||
| Q2 24 | — | 30.1% | ||
| Q1 24 | — | 9.1% |
资本支出强度CBLLELMD
| Q4 25 | 0.7% | 3.4% | ||
| Q3 25 | 1.6% | 1.5% | ||
| Q2 25 | 0.3% | 0.8% | ||
| Q1 25 | 0.7% | 1.0% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.6% |
现金转化率CBLLELMD
| Q4 25 | — | 1.10× | ||
| Q3 25 | — | 0.08× | ||
| Q2 25 | — | 1.75× | ||
| Q1 25 | — | 1.10× | ||
| Q4 24 | — | 1.60× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.46× | ||
| Q1 24 | — | 0.90× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
ELMD
暂无分部数据
